Gray Mary Ann
Keros Therapeutics, Inc. · Director
Gray Mary Ann is listed in public filings as director. This Gray Mary Ann insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Keros Therapeutics, Inc. (KROS), Compass Therapeutics, Inc. (CMPX), and BioAtla, Inc. (BCAB). Investors use Gray Mary Ann's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --12.4k shares | Grant / ExerciseJun 3, 2026 | Disclosure amount unavailable7.1k shares | -- | -- | |
| $78k7.4k shares | Grant / ExerciseJun 3, 2026 | $78.0K7.4k shares | $10.50 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $465k90k shares | Grant / ExerciseJan 2, 2026 | $465.3K90k shares | $5.17 | -- | |
| --77.4k shares | Grant / ExerciseJun 18, 2025 | Disclosure amount unavailable23.5k shares | -- | -- | |
| --5.3k shares | Grant / ExerciseJun 4, 2025 | Disclosure amount unavailable5.3k shares | -- | -- | |
| $156k10.5k shares | Grant / ExerciseJun 4, 2025 | $155.6K10.5k shares | $14.82 | -- | |
| $146k40k shares | Grant / ExerciseFeb 11, 2025 | $146.0K40k shares | $3.65 | -- | |
| --53.9k shares | Grant / ExerciseJun 13, 2024 | Disclosure amount unavailable16.5k shares | -- | -- |